"With 20+ years of research experience and 100 completed study protocols, the Mills Clinical Research team is comprised of highly qualified and trained individuals. Our staff is GCP trained and CCRP certified and, with bilingual employees, we are able to accommodate both English and Spanish speaking patients. With a dedicated recruitment and outreach staff, as well as a patient database of 15,000, we are able to proactively meet our recruitment goals."

During the past decade, Mills Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mills Clinical Research" #1 sponsor was "Gilead Sciences" with 12 trials, followed by "City of Hope Medical Center" with 1 trials sponsored, "Hologic, Inc." with 1 trials sponsored, "Mills Clinical Research" with 1 trials sponsored and "Theratechnologies" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mills Clinical Research" #1 collaborator was "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Excelsus Statistics Inc." with 1 trials as a collaborator, "Health Psychology Research Group (HPR)" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Mills Clinical Research" are "HIV-1 Infection" (7 trials), "HIV-1-infection" (3 trials), "COVID-19" (1 trials), "HCV Infection" (1 trials) and "HIV" (1 trials). Many other conditions were trialed in "Mills Clinical Research" in a lesser frequency.

Most popular intervention types in "Mills Clinical Research" are "Drug" (13 trials), "Biological" (2 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "B/F/TAF" (5 trials), "Placebo" (3 trials), "Oral Lenacapavir" (2 trials), "Subcutaneous Lenacapavir" (2 trials) and "Vesatolimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mills Clinical Research" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Mills Clinical Research". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mills Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mills Clinical Research, 6 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".